Arsani William - 13 Aug 2025 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Reporting relationship: Director
Issuer ticker: DSGN
Reported as of: 13 Aug 2025
Net transaction value: -$2,953,792
SEC form: 4
Accepted by SEC: 14 Aug 2025, 16:15:08 UTC
Prior SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Mustapha Parekh, Attorney-in-Fact

Key filing fact

Arsani William filed Form 4 for Design Therapeutics, Inc. (DSGN) on 14 Aug 2025.

Key facts

This page summarizes Arsani William's Form 4 filing for Design Therapeutics, Inc. (DSGN).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 Aug 2025, 16:15.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: -$2,953,792.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001848372 Primary reporting owner

William Arsani

Relationship: Director
Address: C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD
Signature: /s/ Mustapha Parekh, Attorney-in-Fact
Signature date: 14 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DSGN transaction

Common Stock

Sale

Transaction value: $1,811,250
Shares: -345,000
Change %: -12%
Price: $5.25
Shares after: 2,655,000
Date: 13 Aug 2025
Ownership: By Logos Global Master Fund LP
Footnotes: F1

DSGN transaction

Common Stock

Sale

Transaction value: $1,142,542
Shares: -217,627
Change %: -18%
Price: $5.25
Shares after: 1,000,000
Date: 13 Aug 2025
Ownership: By Logos Opportunities Fund II LP
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Footnote F2

Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. The Reporting Person is the Managing Member of GP I. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.